Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucaresti

Bucharest 022328

0 studies enrolling now · 1 studies all time

What they study most

ALK+ Advanced NSCLC

Studies at this site

• A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer — Completed